Clariant

Clariant in India intends to acquire a part of Vivimed Labs Limited’s personal care portfolio

  • Synergies in product portfolio and customer base to boost Clariant’s personal care segment
  • The acquisition supports Clariant’s strategy to grow its presence in emerging markets

Mumbai, September 29, 2015 – Clariant, a world leader in specialty chemicals, today entered into an agreement with an intent to acquire a part of Vivimed Labs Limited’s personal care portfolio, subject to necessary regulatory, statutory and other approvals, as may be required. The acquisition will enable Clariant India Ltd (a 100% subsidiary of Clariant Group) to strengthen its personal care portfolio within the Industrial & Consumer Specialties (ICS) business unit, by offering a wider product portfolio within the sun, skin, hair and oral care range as well as anti-microbial preservatives.

“The personal care industry in India offers us immense potential, supported by the growing middle-class consumer population and the rising disposable income. This strategic decision will be a significant step towards strengthening our product portfolio and thereby reinforcing Clariant’s long term commitment in the segment,” commented Dr. Deepak Parikh, Region President, India, Middle East and Africa, Clariant. “We believe in the growth potential that India offers and are focussed on expanding our footprint in the region.”

Stephen Lynen, Head ICS, Asia Pacific, Clariant said “This marks an important step in our global strategy to enhance our offering in personal care and to boost our presence in Asia. The transaction will strengthen our portfolio with actives to formulate broader solutions such as sun protection in a strong growing market – India.”

“This reinforces our commitment to grow in the personal care space in India. This acquisition will enable us to expand our footprint and provide our customers with end-to-end solutions in sync with the current industry trends. The strong growth perspective of the personal care industry results in a bright future for the ICS business in India,” added R. Kumaresan, Head of BU ICS, India.

Santosh Varalwar, MD & CEO, Vivimed Labs Limited said “I am pleased to announce an important strategic development at Vivimed. This transaction will help us significantly improve our financial flexibility for future growth. We are confident that this transaction, once completed, will position Vivimed optimally to move to the next level of growth, across its speciality chemicals and pharmaceuticals businesses.”

Reader enquiries

Clariant International Ltd
Rothausstrasse 61
4132 Muttenz 1
Switzerland
+41 61 469 6742
www.clariant.com
@clariant
Clariant
ClariantInternational
clariant_international
The Moleculist Blog

Notes for editors


www.clariant.com

Clariant is a globally leading specialty chemicals company, based in Muttenz near Basel/Switzerland. On December 31, 2014 the company employed a total workforce of 17 003. In the financial year 2014, Clariant recorded sales of CHF 6.116 billion for its continuing businesses. The company reports in four business areas: Care Chemicals, Catalysis, Natural Resources, and Plastics & Coatings. Clariant’s corporate strategy is based on five pillars: increase profitability, reposition portfolio, add value with sustainability, foster innovation and R&D, and intensify growth.

www.clariant.in

Clariant in India, headquartered in Mumbai, operates in four business areas: Care Chemicals, Catalysis & Energy, Natural Resources, and Plastics & Coatings, including businesses like Pigments (Coatings, Printing and Plastics and Special Applications), Additives, Industrial & Consumer Specialties, Mining Services and Masterbatches, thus delivering solutions for the industry and the society. The 900-plus employee strength generated sales of INR 10.08 billion (in 2014). In 2014, Clariant invested in a state-of-the-art Regional Innovation Center in Mumbai, with an aim to co-create tailormade solutions with customers for the industry.

Clariant is committed to Responsible Care® and several external sustainability initiatives such as the Global Product Strategy and the United Nations Global Compact. Clariant is one of the top European chemical companies being part of Dow Jones Sustainability Indices.

 

Editorial enquiries

Carsten Seum
Clariant International Ltd

+41 61 469 63 63
carsten.seum@​clariant.com

Stefanie Nehlsen
Clariant International Ltd

+41 61 469 63 63
stefanie.nehlsen@​clariant.com

Anja Pomrehn
Investor Relations
Clariant International Ltd

+41 61 469 63 73
anja.pomrehn@​clariant.com

Siegfried Schwirzer
Investor Relations
Clariant International Ltd

+41 61 469 6749
siegfried.schwirzer@​clariant.com

Marco Ferraro
Investor Relations
Clariant International Ltd

+41 61 469 64 11
marco.ferraro@​clariant.com

 

Share

 

More news from